| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d185a1d161fee7d8f909c62232080b44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99505f5f312672820e9f78c254c00a4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_914435aac7e9b1b1e0a9c6fa5d15d575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95d7c0eaa68ee59f9c9986e7fb6d0b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07d5dcbb9f91a44c19e14317e706f590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f28306adab6953d083eb8b65acbbad0a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43dc71e24aed53282ace2e552433a8ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ac7975d418ab0d7905eafcd229f882
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bc3f210381331690703f958a6d34381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1faf445f25f60fc5ebd75a913172c156 |
| publicationDate |
2015-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015049371-A1 |
| titleOfInvention |
Methods for predicting the responsiveness of a patient affected with chronic myeloid leukemia (cml) to a treatment with a tyrosine kinase inhibitor (tki) |
| abstract |
The invention relates to a method for predicting the responsiveness of a patient affected by a chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) to a treatment with a tyrosine kinase inhibitor (TKI) comprising the following steps of: a) obtaining a sample from the patient; b) contacting said sample with a TKI; and c) determining the DNA repair capacity of said sample; wherein the responsiveness is predicted when a DNA repair capacity is observed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109475553-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021028909-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022184907-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021156360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017158625-A1 |
| priorityDate |
2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |